PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,601,991 | -16.9% | 39,390 | -1.0% | 0.14% | -32.9% |
| Q1 2023 | $1,926,943 | +17.7% | 39,780 | -7.3% | 0.21% | +15.1% |
| Q4 2022 | $1,637,340 | -10.6% | 42,896 | +17.6% | 0.18% | +2.8% |
| Q3 2022 | $1,831,000 | +9.2% | 36,471 | -4.7% | 0.18% | +13.9% |
| Q2 2022 | $1,676,000 | +36.5% | 38,277 | +16.3% | 0.16% | +75.6% |
| Q1 2022 | $1,228,000 | -78.5% | 32,926 | -77.0% | 0.09% | -75.3% |
| Q4 2021 | $5,709,000 | +1.8% | 143,344 | -4.9% | 0.36% | +0.3% |
| Q3 2021 | $5,609,000 | +3.4% | 150,751 | +17.5% | 0.36% | +1.7% |
| Q2 2021 | $5,425,000 | -15.3% | 128,353 | -5.1% | 0.36% | -22.3% |
| Q1 2021 | $6,404,000 | -8.4% | 135,253 | +18.1% | 0.46% | -11.7% |
| Q4 2020 | $6,991,000 | +52.2% | 114,553 | +22.1% | 0.52% | +27.9% |
| Q3 2020 | $4,592,000 | +37.5% | 93,853 | +42.6% | 0.41% | +22.2% |
| Q2 2020 | $3,339,000 | +24.5% | 65,815 | +9.5% | 0.33% | -4.0% |
| Q1 2020 | $2,682,000 | +10.3% | 60,117 | +18.7% | 0.35% | +33.3% |
| Q4 2019 | $2,432,000 | +220.4% | 50,635 | +125.6% | 0.26% | +196.6% |
| Q3 2019 | $759,000 | – | 22,445 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 161,083 | $9,831,000 | 7.49% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 333,000 | $20,323,000 | 5.55% |
| RTW INVESTMENTS, LP | 4,221,836 | $257,659,000 | 4.32% |
| GEORGE KAISER FAMILY FOUNDATION | 90,011 | $10,766,000 | 2.85% |
| SECTORAL ASSET MANAGEMENT INC | 603,978 | $36,861,000 | 2.60% |
| Redwood Investments, LLC | 364,837 | $22,266,000 | 1.90% |
| ARMISTICE CAPITAL, LLC | 716,000 | $43,697,000 | 1.49% |
| CM Management, LLC | 25,000 | $1,526,000 | 1.42% |
| Third Security, LLC | 237,015 | $14,465,000 | 1.32% |
| Sofinnova Investments, Inc. | 316,478 | $19,315,000 | 1.15% |